header
Image from OpenLibrary

Synergistic activity of colistin and rifampicin combination against multidrug-resistant acinetobacter baumannii In vitro / Reem Heussieny Abdelrazek Metwally ; Supervised Mohamed Ez Eldin Abdelhalim Dawoud , Mohamed Eweis Mahmoud , Doaa Mohammed Ghaith

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Reem Heussieny Abdelrazek Metwally , 2019Description: 158 P. : charts , photographs ; 25cmOther title:
  • النشاط التآزرى لدمج كوليستين و ريفامبيسين ضد بكتريا أسينيتوباكتر بومانّى متعددة المقاومة معملياً [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Botany Microbiology Summary: Members of the genus Acinetobacter have become the focus of many researches due to their pathogenic potential. Interest in Acinetobacter spp. has been growing for the past 30 years. One of the main reasons for the present increased interest in this genus is the emergence of multi-resistant strains, some of which are pan-resistant to antibiotics that suddenly cause an outbreak of infection involving several patients in clinical units. The goal of our study is to analyze the levels of synergy between colistin and rifampin, against isolates with reduced susceptibility to both colistin and rifampin, and their relationship with the minimal inhibitory concentrations (MICs).Over two years; from January 2015 to January 2017 a total of twenty-three clinical isolates of Acinetobacter baumannii showing reduced susceptibility to antibiotic colistin, were collected from multiple Microbiology Laboratories in Cairo university teaching hospitals (The Main old Hospital, Abu Elreech pediatric hospital, Elmanial Specialized Hospital and New Kasr Elainy teaching hospital). All clinical isolates were collected from various sample types.Twenty-three clinical isolates of A. baumannii were collected from different clinical samples types [pus (n=10), blood (n=4), urine (n=4), sputum (n=5)]. Six acinetobacter isolates susceptible to colistin used as control isolates were included in the study.All clinical samples were subjected to standard microbiological processing for identification and processed in the microbiology laboratory according to the standard procedure (CLSI)
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.05.M.Sc.2019.Re.S (Browse shelf(Opens below)) Not for loan 01010110079947000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.05.M.Sc.2019.Re.S (Browse shelf(Opens below)) 79947.CD Not for loan 01020110079947000

Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Botany Microbiology

Members of the genus Acinetobacter have become the focus of many researches due to their pathogenic potential. Interest in Acinetobacter spp. has been growing for the past 30 years. One of the main reasons for the present increased interest in this genus is the emergence of multi-resistant strains, some of which are pan-resistant to antibiotics that suddenly cause an outbreak of infection involving several patients in clinical units. The goal of our study is to analyze the levels of synergy between colistin and rifampin, against isolates with reduced susceptibility to both colistin and rifampin, and their relationship with the minimal inhibitory concentrations (MICs).Over two years; from January 2015 to January 2017 a total of twenty-three clinical isolates of Acinetobacter baumannii showing reduced susceptibility to antibiotic colistin, were collected from multiple Microbiology Laboratories in Cairo university teaching hospitals (The Main old Hospital, Abu Elreech pediatric hospital, Elmanial Specialized Hospital and New Kasr Elainy teaching hospital). All clinical isolates were collected from various sample types.Twenty-three clinical isolates of A. baumannii were collected from different clinical samples types [pus (n=10), blood (n=4), urine (n=4), sputum (n=5)]. Six acinetobacter isolates susceptible to colistin used as control isolates were included in the study.All clinical samples were subjected to standard microbiological processing for identification and processed in the microbiology laboratory according to the standard procedure (CLSI)

Issued also as CD

There are no comments on this title.

to post a comment.